ACADIA Pharmaceuticals Inc. vs Krispy Kreme Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.06B), while Krispy Kreme Inc trades at $3.12 (market cap $544.79M). The key difference: ACADIA Pharmaceuticals Inc. is far larger — about 9.3× Krispy Kreme Inc's market cap, and Krispy Kreme Inc pays a 3.47% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | DNUT | |
|---|---|---|
Market Cap | $5.06B | $544.79M |
Sector | Health | Consumer Staples |
52-Week High | $29.41 | $4.70 |
52-Week Low | $20.06 | $2.92 |
Enterprise Value | $4.18B | $1.79B |
Dividend Yield | — | 3.47% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates in 30 countries through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S. and Canada, includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line
Read more on DNUT →